As the health care industry’s most comprehensive library of customizable policy and procedure templates, MCN Healthcare’s Behavioral Health Partial Hospitalization Program Policy and Procedure Manual includes this customizable template, Investigational Drugs. MCN’s policy library helps you meet compliance with Joint Commission and federal regulations including CMS, CDC, OSHA, OIG, HIPAA and more.

MCN’s templates save you time, money and resources, rather than developing healthcare policy and procedure manuals from scratch.

Here is some sample content from Investigational Drugs:

	POLICY: Investigational drugs will refer to those drugs which have not yet been released by the Federal Food and Drug Administration for general use. Therefore, they will include drugs bearing the following cautionary labeling CAUTION New Drug -- Limited by Federal Law to Investigational Use. does not conduct investigational studies, but may elect to participate in one for the purpose of continuing a current course of therapy if it is in the best interest of the patient to do so. Department of Pharmacy, through the pharmacy and therapeutics function, shall participate, as required, in...
Second excerpt:
	...which the orders for the investigational drug will be. Other dispensing requirements shall be as prescribed by the sponsor and investigator. On approval of the principal investigator, practitioners authorized to use the drug or registered nurses may administer these drugs. Nurses shall not administer these drugs until they have been provided with basic pharmacologic information about the drugs and have attested to an understanding of this information. Disposition Upon Dismissal of...